These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 6752567)
21. [The effect of platyphyllin-electrophoresis on lipid metabolism in coronary atherosclerosis]. Levina LA; Evnina II Vrach Delo; 1968 Jun; 6():144-6. PubMed ID: 5736156 [No Abstract] [Full Text] [Related]
22. The overnight urinary reducing substances test in degenerative vascular diseases. Campbell DG N Z Med J; 1966 Aug; 65(408):533-5. PubMed ID: 5223729 [No Abstract] [Full Text] [Related]
23. [Studies of I 131-insulin metabolism in chronic circulatory insufficiency]. Leshchinskiĭ LA; Trusov VV; Pimenov LT Ter Arkh; 1977; 49(5):54-8. PubMed ID: 877895 [No Abstract] [Full Text] [Related]
24. [Relations of the carbohydrate and lipid metabolic indices in ischemic heart disease]. Polishchuk II Vrach Delo; 1983 Sep; (9):34-7. PubMed ID: 6649569 [No Abstract] [Full Text] [Related]
25. The role of endogenous insulin in different hyperlipidemic states. Tzagournis M; Chiles R; Herrold J; Skillman T Diabetologia; 1972 Jul; 8(3):215-20. PubMed ID: 5047263 [No Abstract] [Full Text] [Related]
26. [Dynamics of electrolyte-enzyme metabolism in coronary atherosclerosis]. Getmanets RA Vrach Delo; 1971 Nov; 11():21-5. PubMed ID: 5143268 [No Abstract] [Full Text] [Related]
29. States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990. Am Heart J; 1991 Apr; 121(4 Pt 2):1267-318. PubMed ID: 1672574 [No Abstract] [Full Text] [Related]
30. [Electrolyte metabolism in patients with chronic coronary insufficiency]. Grigor'eva ZE Vrach Delo; 1969 Oct; 10():152-3. PubMed ID: 5366799 [No Abstract] [Full Text] [Related]
31. [Current status of our knowledge on cardiopathies caused by coronary atherosclerosis]. Lenègre J Brux Med; 1966 Feb; 46(9):217-33. PubMed ID: 5905943 [No Abstract] [Full Text] [Related]
32. [Disorder of oxidation-reduction processes in various forms of coronary insufficiency and their dynamics as a function of the therapy applied]. Katkova NB Ter Arkh; 1966 Jul; 38(7):32-4. PubMed ID: 5999727 [No Abstract] [Full Text] [Related]
33. [Significance of hypertriglyceridemia in coronary atherosclerosis]. Baltă N; Drăgulescu N; Metz L; Roşca M Fiziol Norm Patol; 1971; 17(4):341-8. PubMed ID: 5097003 [No Abstract] [Full Text] [Related]
34. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting]. Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029 [TBL] [Abstract][Full Text] [Related]
36. Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Parks EJ Br J Nutr; 2002 May; 87 Suppl 2():S247-53. PubMed ID: 12088525 [TBL] [Abstract][Full Text] [Related]